Literature DB >> 26003255

Lower urinary tract dysfunction in patients with multiple sclerosis.

Jalesh N Panicker1, Clare J Fowler2.   

Abstract

Lower urinary tract (LUT) dysfunction is common in multiple sclerosis (MS), and has a considerable impact on quality of life. It most often results from involvement of the spinal cord, which results in detrusor overactivity and detrusor sphincter dyssynergia. LUT symptoms may change with time, paralleling the dynamic course of MS, and therefore the need for regular follow-up assessments is essential. A formal evaluation includes history taking, measurement of the postvoid residual volume (PVR), testing for urinary tract infections and urodynamic studies in select cases. If the PVR is elevated, incomplete bladder emptying is best managed by intermittent self-catheterization. Several options exist for managing the overactive bladder, including antimuscarinics, desmopressin, tibial nerve stimulation, and botulinum toxin A. A stepwise approach is adopted for managing LUT dysfunction in MS.
© 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  antimuscarinics; botulinum toxin neurostimulation; detrusor overactivity; incontinence; multiple sclerosis; overactive bladder

Mesh:

Year:  2015        PMID: 26003255     DOI: 10.1016/B978-0-444-63247-0.00021-3

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  7 in total

1.  Nocturia in Patients With Multiple Sclerosis.

Authors:  Benoit Peyronnet; Lauren B Krupp; W Stuart Reynolds; Xavier Gamé; Gérard Amarenco; Jean-Nicolas Cornu; Lana Zhovtis Ryerson; Carrie Lyn Sammarco; Jonathan E Howard; Robert W Charlson; Roger R Dmochowski; Benjamin M Brucker
Journal:  Rev Urol       Date:  2019

Review 2.  Neurogenic lower urinary tract dysfunction: evaluation and management.

Authors:  Katarina Ivana Tudor; Ryuji Sakakibara; Jalesh N Panicker
Journal:  J Neurol       Date:  2016-07-11       Impact factor: 4.849

Review 3.  Neurogenic lower urinary tract dysfunction in multiple sclerosis, neuromyelitis optica, and related disorders.

Authors:  Ryuji Sakakibara
Journal:  Clin Auton Res       Date:  2018-08-03       Impact factor: 4.435

4.  Patient-Reported Bladder, Bowel, and Sexual Function After Cauda Equina Syndrome Secondary to a Herniated Lumbar Intervertebral Disc.

Authors:  Jordan Lam; Ruth-Mary deSouza; Jonathan Laycock; Duranka Perera; Charlotte Burford; Baha Khan; Gordan Grahovac
Journal:  Top Spinal Cord Inj Rehabil       Date:  2021-01-20

5.  Lower urinary tract symptoms and sexual dysfunction in men with multiple sclerosis.

Authors:  André Luiz Farinhas Tomé; Eduardo P Miranda; José de Bessa Júnior; Carlos Alberto Bezerra; Antônio Carlos Lima Pompeo; Sidney Glina; Cristiano Mendes Gomes
Journal:  Clinics (Sao Paulo)       Date:  2019-03-14       Impact factor: 2.365

6.  Antimuscarinics for neurogenic overactive bladder in multiple sclerosis: real-life data.

Authors:  Elena Andretta; Enrico Finazzi Agrò; Massimiliano Calabrese; Luca Orecchia; Antonietta Furlan; Cristina Zuliani
Journal:  Ther Adv Urol       Date:  2022-09-24

7.  Intradetrusorial Botulinum Toxin in Patients with Multiple Sclerosis: A Neurophysiological Study.

Authors:  Antonella Conte; Antonella Giannantoni; Marilena Gubbiotti; Simona Pontecorvo; Enrico Millefiorini; Ada Francia; Massimo Porena; Alfredo Berardelli
Journal:  Toxins (Basel)       Date:  2015-08-26       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.